Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 7,861-7,872 of 10,612

Drug study icon

CompletedNCT00365209

Phase II A study of Curcumin Among people with Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 40 Years

Countries: United States
Sponsor: National Cancer Institute (NCI)
Condition: Addiction

Behavioral study icon

Active Not RecruitingNCT04806516

Phase II Adaptive Deep Brain Stimulation for OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDBehavioralFrom 18 Years to 70 Years

Countries: United States
Sponsor: Baylor College of Medicine
Condition: OCD

Behavioral study icon

CompletedNCT02264327

Phase II Motivational Interviewing: An Experiential Online Training Tool

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

AddictionBehavioralFrom 21 Years to 70 Years

Countries: United States
Sponsor: Center for Social Innovation, Massachusetts
Condition: Addiction

Drug study icon

CompletedNCT02710526

Phase II Pharmacokinetics Study of CAM2038

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 19 Years to 65 Years

Countries: United States
Sponsor: Braeburn Pharmaceuticals
Condition: Addiction

Drug study icon

CompletedNCT02933606

Phase II Study of BNC210 in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 70 Years

Countries: United States, Australia
Sponsor: Bionomics Limited
Condition: PTSD

Drug study icon

CompletedNCT00322764

RG2417 for depression

This study is completed in the United States. It is testing RG2417 for depression.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Repligen Corporation
Condition: Bipolarity, Depression

Device study icon

SuspendedNCT05394545

Phase II study of Nu-V3 Non-Invasive Nerve Stimulation Device for Chronic Pain, Anxiety, Depression, Sleeplessness

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, AnxietyDeviceOver 18 Years

Countries: United States
Sponsor: Nu-Life Solutions
Condition: Depression, Anxiety

Drug study icon

CompletedNCT00686998

Phase IIA Study in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: AstraZeneca
Condition: Schizophrenia

Drug study icon

Enrolling By InvitationNCT06605105

Phase III Long-term Extension study to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 85 Years

Countries: United States, Australia
Sponsor: Cybin IRL Limited
Condition: Depression

Drug study icon

CompletedNCT00422214

Phase III/Seroquel SR Depression in bipolarity Monotherapy - US

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, Depression, ...DrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: AstraZeneca
Condition: Bipolarity, Depression, ...

Behavioral study icon

CompletedNCT00862212

Phased Treatment for Social Anxiety Disorder and Coping Behaviors in a Medical Setting

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AnxietyBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: Anxiety

Drug study icon

CompletedNCT00691132

Phenethyl Isothiocyanate in Preventing Lung Cancer in Smokers

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 70 Years

Countries: United States
Sponsor: University of Minnesota
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.